18 Jul 2018 | 10:25 PM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
554.71
-8.40
(-1.49 %)
18 Jul 2018 | 03:54 PM
Change company
  • Open (Rs)
    567.00
  • Prev. close (Rs.)
    563.10
  • High (Rs.)
    569.80
  • Low (Rs.)
    548.30
  • 52W H (Rs.)
    720.90
  • 52W L (Rs.)
    483.60
  • Volume
    29644
  • MCap (Rs in Cr.)
    15,651.86
556.5
-8.75
(-1.55 %)
  • Open (Rs)
    569.90
  • High (Rs)
    571.40
  • Low (Rs)
    548.35
  • Prev. close(Rs)
    565.25
  • Contracts Tra.
    13,21,000
  • Turnover (Cr.)
    73
  • Open Interest
    45,27,000
  • Open Int. chg
    -9,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.30
Operating Margin (%)
23.32
Gross Profit Margin (%)
20.45
Net Profit Margin (%)
12.07
Total Debt/Equity
1.05
Dividend payout Ratio (Net Profit)
6.12
Earning Retention Ratio
94.76

News

17 Jul 2018 - 14:40:00-Drug firm Glenmark Pharmaceuticals today said it will file an appeal against the order of the Compet...
17 Jul 2018 - 10:30:00-Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food...
16 Jul 2018 - 15:53:00-The Competition Commission today imposed penalties totalling nearly Rs 47 crore on Glenmark Pharmace...
10 Jul 2018 - 14:46:00-Glenmark Pharmaceuticals and Swiss pharma group Helsinn today announced the launch of Akynzeo a fixe...

Announcements

17-Jul-2018
Glenmark Pharma - Shareholding for the Period Ended June 30 2018
17-Jul-2018
Glenmark Pharma - News Clarification
17-Jul-2018
Glenmark Pharma - Glenmark Pharmaceuticals Ltd reply to clarification sought by the exchange
17-Jul-2018
Glenmark Pharma - Press Release
16-Jul-2018
Glenmark Pharma - Acquisition

Religare Research

18 Jul 2018 | 10:24 AM
DTF
18 Jul 2018 | 10:12 AM
The rupee settled at 68.45 to a dollar, its highest since Jun. 26, and against 68.57 at previous clo...
18 Jul 2018 | 07:00 AM
We reiterate our positive view on Nifty but advise keeping caution on broader front. Prefer options ...
17 Jul 2018 | 10:40 AM
DTF

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 73.29 -0.46
10,00,000 115.06 63.27 -0.46
10,00,000 115.06 204.76 -0.46
10,00,000 115.06 213.88 -0.46
10,00,000 115.06 77.35 -0.46

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI4.01%
FI/Banks2.94%
Insurance2.94%
FII30.61%
Government0.00%
Others5.21%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,151.05(1.67)
3280
 Sanofi India Ltd.
5,502.00(-0.89)
3325
 GlaxoSmithKline Pharmaceuticals Ltd.
2,790.00(-1.72)
3317
 Pfizer Ltd.
2,579.25(1.11)
3370

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.-27.60-19.10-75.25
NIFTY(S&P CNX)180.60431.75191.90
BSE SENSEX825.181,978.381,291.62
BSE 500-71.82-81.12-621.78

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda